Psychoneuroendocrinology
Volume 34, Issue 7 , Pages 1004-1011 , August 2009

Depressive symptoms and metabolic risk: Effects of cortisol and gender

  • Christoph Muhtz

      Affiliations

    • Department of Psychiatry and Psychotherapy, University Hospital Hamburg-Eppendorf, Martinistrasse 52, 20246 Hamburg, Germany
    • Corresponding Author InformationCorresponding author. Tel.: +49 40 42803 3232; fax: +49 40 42803 3461.
    • ,
  • Birgit-Christiane Zyriax

      Affiliations

    • Division of Endocrinology and Metabolism of Ageing, University Hospital Hamburg-Eppendorf, Hamburg, Germany
    • ,
  • Tilman Klähn

      Affiliations

    • Bethesda Hospital Bergedorf, Hamburg, Germany
    • ,
  • Eberhard Windler

      Affiliations

    • Division of Endocrinology and Metabolism of Ageing, University Hospital Hamburg-Eppendorf, Hamburg, Germany
    • ,
  • Christian Otte

      Affiliations

    • Department of Psychiatry and Psychotherapy, University Hospital Hamburg-Eppendorf, Martinistrasse 52, 20246 Hamburg, Germany

Received 13 December 2008 ,Revised 23 January 2009 ,Accepted 28 January 2009.

References 

  1. Alberti KGMM, Zimmet P, Shaw J. The metabolic syndrome—a new worldwide definition. Lancet. 2005;366:1059
  2. Bjorntorp P. Do stress reactions cause abdominal obesity and comorbidities?. Obes. Rev. 2001;2:73–86
  3. Boyle SH, Surwit RS, Georgiades A, Brummett BH, Helms MJ, Williams RB, et al. Depressive symptoms, race, and glucose concentrations: the role of cortisol as mediator. Diabetes Care. 2007;30:2484–2488
  4. Brown ES, Varghese FP, McEwen BS. Association of depression with medical illness: does cortisol play a role?. Biol. Psychiatry. 2004;55:1–9
  5. Brunner EJ, Hemingway H, Walker BR, Page M, Clarke P, Juneja M, et al. Adrenocortical, autonomic, and inflammatory causes of the metabolic syndrome: nested case–control study. Circulation. 2002;106:2659–2665
  6. Capuron L, Su S, Miller AH, Bremner JD, Goldberg J, Vogt GJ, et al. Depressive symptoms and metabolic syndrome: is inflammation the underlying link?. Biol. Psychiatry. 2008;64:896–900
  7. Deuschle M, Schweiger U, Weber B, Gotthardt U, Korner A, Schmider J, et al. Diurnal activity and pulsatility of the hypothalamus–pituitary–adrenal system in male depressed patients and healthy controls. J. Clin. Endocrinol. Metab. 1997;82:234–238
  8. Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome among US adults: findings from the Third National Health and Nutrition Examination Survey. JAMA. 2002;287:356–359
  9. Golden SH, Lazo M, Carnethon M, Bertoni AG, Schreiner PJ, Roux AVD, et al. Examining a bidirectional association between depressive symptoms and diabetes. JAMA. 2008;299:2751–2759
  10. Halbreich U, Asnis GM, Shindledecker R, Zumoff B, Nathan RS. Cortisol secretion in endogenous depression. II. Time-related functions. Arch. Gen. Psychiatry. 1985;42:909–914
  11. Herva A, Rasanen P, Miettunen J, Timonen M, Laksy K, Veijola J, et al. Co-occurrence of metabolic syndrome with depression and anxiety in young adults: the Northern Finland 1966 Birth Cohort Study. Psychosom. Med. 2006;68:213–216
  12. Keller J, Flores B, Gomez RG, Solvason HB, Kenna H, Williams GH, et al. Cortisol circadian rhythm alterations in psychotic major depression. Biol. Psychiatry. 2006;60:275
  13. Kessler RC, Berglund P, Demler O, Jin R, Koretz D, Merikangas KR, et al. The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R). JAMA. 2003;289:3095–3105
  14. Kessler RC, McGonagle KA, Zhao S, Nelson CB, Hughes M, Eshleman S, et al. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey. Arch. Gen. Psychiatry. 1994;51:8–19
  15. Kinder LS, Carnethon MR, Palaniappan LP, King AC, Fortmann SP. Depression and the metabolic syndrome in young adults: findings from the Third National Health and Nutrition Examination Survey. Psychosom. Med. 2004;66:316–322
  16. Knol MJ, Twisk JW, Beekman AT, Heine RJ, Snoek FJ, Pouwer F. Depression as a risk factor for the onset of type 2 diabetes mellitus. A meta-analysis. Diabetologia. 2006;49:837–845
  17. Koponen H, Jokelainen J, Keinänen-Kiukaanniemi S, Kumpusalo E, Vanhala M. Metabolic syndrome predisposes to depressive symptoms: a population-based 7-year follow-up study. J. Clin. Psychiatry. 2007;69:178–182
  18. Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J. Gen. Intern. Med. 2001;16:606–613
  19. Lakka H-M, Laaksonen DE, Lakka TA, Niskanen LK, Kumpusalo E, Tuomilehto J, et al. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA. 2002;288:2709–2716
  20. Lowe B, Spitzer RL, Grafe K, Kroenke K, Quenter A, Zipfel S, et al. Comparative validity of three screening questionnaires for DSM-IV depressive disorders and physicians’ diagnoses. J. Affect. Disord. 2004;78:131–140
  21. McCaffery JM, Niaura R, Todaro JF, Swan GE, Carmelli D. Depressive symptoms and metabolic risk in adult male twins enrolled in the National Heart, Lung, and Blood Institute twin study. Psychosom. Med. 2003;65:490–497
  22. McManus D, Pipkin SS, Whooley MA. Screening for depression in patients with coronary heart disease (data from the Heart and Soul Study). Am. J. Cardiol. 2005;96:1076
  23. Moebus S, Stang A. Das metabolisches Syndrom—ein umstrittenes diagnostisches Konzept. Herz. 2007;32:529
  24. Nelson JC, Davis JM. DST studies in psychotic depression: a meta-analysis. Am. J. Psychiatry. 1997;154:1497–1503
  25. Otte C, Hart S, Neylan T, Yaffe K, Marmar C, Mohr D. A meta-analyis of cortisol response in human aging: importance of gender. Psychoneuroendocrinology. 2005;30:80–91
  26. Otte C, Marmar CR, Pipkin SS, Moos R, Browner WS, Whooley MA. Depression and 24-hour urinary cortisol in medical outpatients with coronary heart disease: The Heart and Soul Study. Biol. Psychiatry. 2004;56:241–247
  27. Otte C, McCaffery J, Ali S, Whooley MA. Association of a serotonin transporter polymorphism (5-HTTLPR) with depression, perceived stress, and norepinephrine in patients with coronary disease: The Heart and Soul Study. Am. J. Psychiatry. 2007;164:1379–1384
  28. Otte C, Neylan TC, Pipkin SS, Browner WS, Whooley MA. Depressive symptoms and 24-hour urinary norepinephrine excretion levels in patients with coronary disease: findings from the Heart and Soul Study. Am. J. Psychiatry. 2005;162:2139–2145
  29. Penninx BW, Beekman AT, Honig A, Deeg DJ, Schoevers RA, van Eijk JT, et al. Depression and cardiac mortality: results from a community-based longitudinal study. Arch. Gen. Psychiatry. 2001;58:221–227
  30. Penninx BWJH, Beekman ATF, Bandinelli S, Corsi AM, Bremmer M, Hoogendijk WJ, et al. Late-life depressive symptoms are associated with both hyperactivity and hypoactivity of the hypothalamo–pituitary–adrenal axis. Am. J. Geriatr. Psychiatry. 2007;15:522–529
  31. Pfohl B, Sherman B, Schlechte J, Stone R. Pituitary–adrenal axis rhythm disturbances in psychiatric depression. Arch. Gen. Psychiatry. 1985;42:897–903
  32. Raikkonen K, Matthews KA, Kuller LH. Depressive symptoms and stressful life events predict metabolic syndrome among middle-aged women: a comparison of World Health Organization, Adult Treatment Panel III, and International Diabetes Foundation definitions. Diabetes Care. 2007;30:872–877
  33. Raikkönen K, Matthews KA, Kuller LH. The relationship between psychological risk attributes and the metabolic syndrome in healthy women: antecedent or consequence?. Metabolism. 2002;51:1573
  34. Regitz-Zagrosek V, Lehmkuhl E, Mahmoodzadeh S. Gender aspects of the role of the metabolic syndrome as a risk factor for cardiovascular disease. Gend. Med. 2007;4:162–177
  35. Rosmond R, Dallman MF, Bjorntorp P. Stress-related cortisol secretion in men: relationships with abdominal obesity and endocrine, metabolic and hemodynamic abnormalities. J. Clin. Endocrinol. Metab. 1998;83:1853–1859
  36. Rutledge T, Reis SE, Olson MB, Owens J, Kelsey SF, Pepine CJ, et al. Depression symptom severity and reported treatment history in the prediction of cardiac risk in women with suspected myocardial ischemia: The NHLBI-Sponsored WISE Study. Arch. Gen. Psychiatry. 2006;63:874–880
  37. Rutter MK, Meigs JB, Sullivan LM, D’Agostino RB, Wilson PW. Insulin resistance, the metabolic syndrome, and incident cardiovascular events in the Framingham Offspring Study. Diabetes. 2005;54:3252–3257
  38. Skilton MR, Moulin P, Terra J-L, Bonnet F. Associations between anxiety, depression, and the metabolic syndrome. Biol. Psychiatry. 2007;62:1251
  39. Spitzer RL, Kroenke K, Williams JB. Validation and utility of a self-report version of PRIME-MD: the PHQ primary care study. Primary care evaluation of mental disorders. Patient Health Questionnaire. JAMA. 1999;282:1737–1744
  40. Steptoe A, Kunz-Ebrecht SR, Brydon L, Wardle J. Central adiposity and cortisol responses to waking in middle-aged men and women. Int. J. Obes. Relat. Metab. Disord. 2004;28:1168
  41. Toker S, Shirom A, Melamed S. Depression and the metabolic syndrome: gender-dependent associations. Depress. Anxiety. 2008;25:661–669
  42. Vaccarino V, McClure C, Johnson BD, Sheps DS, Bittner V, Rutledge T, et al. Depression, the metabolic syndrome and cardiovascular risk. Psychosom. Med. 2008;70:40–48
  43. Vogelzangs N, Beekman ATF, Kritchevsky SB, Newman AB, Pahor M, Yaffe K, et al. Psychosocial risk factors and the metabolic syndrome in elderly persons: findings from the Health, Aging and Body Composition Study. J. Gerontol. A: Biol. Sci. Med. Sci. 2007;62:563–569
  44. Vogelzangs N, Suthers K, Ferrucci L, Simonsick EM, Ble A, Schrager M, et al. Hypercortisolemic depression is associated with the metabolic syndrome in late-life. Psychoneuroendocrinology. 2007;32:151
  45. Weber-Hamann B, Hentschel F, Kniest A, Deuschle M, Colla M, Lederbogen F, et al. Hypercortisolemic depression is associated with increased intra-abdominal fat. Psychosom. Med. 2002;64:274–277
  46. Weber-Hamann B, Werner M, Hentschel F, Bindeballe N, Lederbogen F, Deuschle M, et al. Metabolic changes in elderly patients with major depression: evidence for increased accumulation of visceral fat at follow-up. Psychoneuroendocrinology. 2006;31:347
  47. WHO, 2007. http://www.who.int/whosis/whostat2007_10highlights.pdf.
  48. Whooley MA. Depression and cardiovascular disease: healing the broken-hearted. JAMA. 2006;295:2874–2881
  49. Wittchen H-U, Jacobi F. Size and burden of mental disorders in Europe—a critical review and appraisal of 27 studies. Eur. Neuropsychopharmacol. 2005;15:357
  50. Yehuda R, Teicher MH, Trestman RL, Levengood RA, Siever LJ. Cortisol regulation in posttraumatic stress disorder and major depression: a chronobiological analysis. Biol. Psychiatry. 1996;40:79–88
  51. Young E, Korszun A. The hypothalamic–pituitary–gonadal axis in mood disorders. Endocrinol. Metab. Clin. North Am. 2002;31:63–78
  52. Young EA, Carlson NE, Brown MB. Twenty-four-hour ACTH and cortisol pulsatility in depressed women. Neuropsychopharmacology. 2001;25:267–276
  53. Young EA, Ribeiro SC, Ye W. Sex differences in ACTH pulsatility following metyrapone blockade in patients with major depression. Psychoneuroendocrinology. 2007;32:503
  54. Yusuf S, Hawken S, Ôunpuu S, Dans T, Avezum A, Lanas F, et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case–control study. Lancet. 2004;364:937–952

PII: S0306-4530(09)00034-1

doi: 10.1016/j.psyneuen.2009.01.016

Psychoneuroendocrinology
Volume 34, Issue 7 , Pages 1004-1011 , August 2009

Article Tools

* Image Usage & Resolution